Part 6/10:
As RFK Jr. delves into the practices surrounding the National Institutes of Health (NIH) and how their funding ties may have led to skewed research outcomes, he poses critical questions about the integrity of scientific research. He highlights unethical associations between researchers and pharmaceutical companies, where financial incentives may have dictated research direction instead of patient safety or health advancements.